Get the Stockscreener App
71.55
0.72%
-0.50
Henry Schein Inc stock is traded at $71.55, with a volume of 118.61K.
It is down -0.72% in the last 24 hours and up +10.51% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$72.05
Open:
$71.59
24h Volume:
118.61K
Relative Volume:
0.07
Market Cap:
$8.71B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
29.32
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+1.50%
1M Performance:
+10.51%
6M Performance:
-4.42%
1Y Performance:
-4.12%
1-Day Range:
$70.80
$71.77
1-Week Range:
$69.64
$72.11
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.53 | 8.58B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
722.91 | 85.94B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
293.12 | 53.93B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
154.35 | 35.47B | 222.29B | 1.56B | 2.44B | 6.41 |
|
YI
111 Inc Adr
|
7.80 | 69.17M | 2.05B | -45.99M | 5.54M | -0.5634 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein Stock Post Earnings Review (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC) Completes $250 Million Private Placement wit - GuruFocus
Henry Schein secures $250 million investment from KKR By Investing.com - Investing.com South Africa
Henry Schein Finalizes $250 Million KKR Investment, Expands Board Leadership - Orthodontic Products
Henry Schein Announces Completion of Strategic Investment by KKR - GuruFocus
Henry Schein Completes $250M Deal with KKR - TipRanks
KKR Closes $250 Million Investment in Henry Schein - marketscreener.com
Henry Schein Announces Completion Of Strategic Investment By Kkr And Appointment Of Dan Daniel To Board Of Directors - marketscreener.com
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors - Business Wire
HSIC Q1 Earnings Call: Henry Schein Navigates Flat Revenue with Margin Resilience and Strategic Shifts - Yahoo Finance
Here's Why Shareholders Should Examine Henry Schein, Inc.'s (NASDAQ:HSIC) CEO Compensation Package More Closely - simplywall.st
Dental Diagnostics and Surgical Equipment Market Forecast Report 2025-2033 with Competitive Analysis of Key PlayersDanaher, Straumann, and Henry Schein - GlobeNewswire
Henry Schein to Participate in Upcoming Investor Conference in June - Dentistry Today
Henry Schein to Participate in Upcoming Investor Conference in J - GuruFocus
Henry Schein price target lowered to $75 from $80 at Wells Fargo - MSN
Henry Schein at Bank of America 2025 Healthcare Conference: Strategic Growth Plans - Investing.com India
Henry Schein at Bank of America 2025 Healthcare Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Transcript : Henry Schein, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 10 - marketscreener.com
Henry Schein's (NASDAQ:HSIC) Strong Earnings Are Of Good Quality - Yahoo Finance
Henry Schein outlines 2025 growth targets amid strategic restructuring and stable market conditions - MSN
Henry Schein misses quarterly revenue estimates on weak demand for dental products - MSN
Henry Schein First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Dental Consumables Market Projected to Hit USD 70.55 Billion by 2032 Amid Rising Demand for Aesthetic and Restorative Dental Care – SNS Insider - GlobeNewswire Inc.
Henry Schein (HSIC) Maintains 'Outperform' Rating Despite Price Target Adjustment | HSIC Stock News - GuruFocus
Henry Schein Schedules May Investor Presentations - Dentistry Today
Barrington Research Adjusts Henry Schein Price Target to $86 From $90, Maintains Outperform Rating - marketscreener.com
Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst - GuruFocus
Henry Schein (HSIC) Price Target Lowered by Wells Fargo Analyst | HSIC Stock News - GuruFocus
What 6 Analyst Ratings Have To Say About Henry Schein - Benzinga
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results - Benzinga
Henry Schein (HSIC) Sees Price Target Cut Despite Strong Q1 Repo - GuruFocus
Henry Schein, Inc. (NASDAQ:HSIC) Q1 2025 Earnings Call Transcript - Insider Monkey
Henry Schein Positioned for Growth: Buy Rating Reaffirmed Amid Strategic Expansion and Board Expertise - TipRanks
Henry Schein (HSIC) Sees Price Target Cut Despite Strong Q1 Report | HSIC Stock News - GuruFocus
Henry Schein to Participate in Upcoming Investor Conferences in May | HSIC Stock News - GuruFocus
Wells Fargo Adjusts Price Target for Henry Schein (HSIC) | HSIC Stock News - GuruFocus
Henry Schein Reports First Quarter 2025 Financial Results - Zenopa
Henry Schein to Participate in Upcoming Investor Conferences in May 2025 - BioSpace
Henry Schein to Participate in Upcoming Investor Conferences in May - Business Wire
Henry Schein Inc (HSIC) Q1 2025 Earnings Call Highlights: Strategic Growth Amid Currency Challenges - Yahoo Finance
Henry Schein Inc (HSIC) Q1 2025 Earnings Call Highlights: Strate - GuruFocus
Earnings call transcript: Henry Schein Q1 2025 sees modest EPS beat, stock dips - Investing.com Canada
Henry Schein Reports Strong Q1 2025 Earnings - TipRanks
Henry Schein: Q1 Earnings Snapshot - MySA
Henry Schein’s Earnings Call: Balancing Growth and Challenges - TipRanks
Henry Schein Dental Merchandise Sales Up, Equipment Flat in Q1 2025 Reporting - Orthodontic Products
Henry Schein's Q1 2025 Earnings: What to Expect - MSN
Henry Schein Reports First Quarter 2025 Financial Results | HSIC Stock News - GuruFocus
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.17%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):